Combination therapy of T cell activating bispecific antigen binding molecules CD3 ABD folate receptor 1 (FolRl) and PD-1 axis binding antagonists

• 收藏
• 分享

专利权人:

F. Hoffmann-La Roche AG

发明人:

Klein, Christian,Karanikas, Vaios,Umana, Pablo,Zippelius, Alfred,Thommen, Daniela,Schreiner, Jens

申请号：

AU2015348657

公开号：

AU2015348657A1

申请日:

2015.11.16

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

The present invention generally relates to T cell activating bispecific antigen binding molecules, PD-1 axis binding antagonists, and in particular to combination therapies employing such T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonists, and their use of these combination therapies for the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/